Effect of Calcineurin Inhibitors and Mammalian Target of Rapamycin Inhibitors on the Course of COVID-19 in Kidney Transplant Recipients

Coronavirus disease 19 (COVID-19) has been an ongoing pandemic since December 2019. Unfortunately, kidney transplant recipients are a high-risk group during the disease course, and scientific data are still limited in this patient group. Beyond the dosage of immunosuppressive drugs, pharmacological...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasbal, Nuri Baris, Turgut, Didem, Oguz, Ebru Gok, Ulu, Sena, Gungor, Ozkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962418/
https://www.ncbi.nlm.nih.gov/pubmed/33707409
http://dx.doi.org/10.12659/AOT.929279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962418/
https://www.ncbi.nlm.nih.gov/pubmed/33707409
http://dx.doi.org/10.12659/AOT.929279

Ejemplares similares